Oculis Holding AG (OCS) Current Assets (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Current Assets came in at $289.9 million in Q1 2026, up 38.07% year-on-year from $210.0 million in Q1 2025, and up 5.86% quarter-over-quarter from $273.9 million in Q4 2025.

Oculis Holding AG (OCS) Current Assets (2021 - 2026) Analysis & Trends

Oculis Holding AG's Current Assets history runs 6 years deep, the most recent figure standing at $289.9 million for Q1 2026.

  • On a quarterly basis, Current Assets rose 38.07% year-over-year to $289.9 million in Q1 2026; TTM through Mar 2026 was $289.9 million, a 38.07% increase from a year earlier, with the FY2025 full-year figure at $264.0 million, up 121.42% from the prior year.
  • Current Assets climbed to $289.9 million in Q1 2026 per OCS's latest filing, from $273.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $289.9 million in Q1 2026 and bottomed at $24.6 million in Q4 2022.
  • The 5-year median for Current Assets is $135.0 million (2023), against an average of $157.8 million.
  • Across the five-year window, Current Assets tumbled 52.81% in 2022 and jumped 363.75% in 2023, its largest moves.
  • Year by year, Current Assets stood at $24.6 million in 2022, then jumped by 363.75% to $113.9 million in 2023, then rose by 5.15% to $119.7 million in 2024, then jumped by 128.71% to $273.9 million in 2025, then gained by 5.86% to $289.9 million in 2026.
  • Per Business Quant, the three latest OCS Current Assets figures stand at $289.9 million (Q1 2026), $273.9 million (Q4 2025), and $188.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 289.93 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 73.04 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 3.59 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 6.60 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 11.73 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 18.21 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 521.86 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.97 Bn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn 4.22 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 289.93 Mn
Dec 31, 2025 273.87 Mn
Sep 30, 2025 188.65 Mn
Jun 30, 2025 200.75 Mn
Mar 31, 2025 209.98 Mn
Dec 31, 2024 119.74 Mn
Sep 30, 2024 128.68 Mn
Jun 30, 2024 137.82 Mn
Mar 31, 2024 97.89 Mn
Dec 31, 2023 113.88 Mn
Sep 30, 2023 130.76 Mn
Jun 30, 2023 134.98 Mn
Dec 31, 2022 24.56 Mn
Dec 31, 2021 52.04 Mn